Biotech giant opens ‘Lab of the Future’ in Marlborough
October 3, 2014
MARLBOROUGH – Quest Diagnostics promised to improve the way health care is delivered in the United States during the unveiling of its new Marlborough facility and its “Lab of the Future” Thursday.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.